Checchi Capital Advisers’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.36M | Sell |
2,709
-2
| -0.1% | -$960 | 0.06% | 169 |
|
|
2026
Q1 | $1.33M | Buy |
2,711
+180
| +7% | +$97.7K | 0.07% | 177 |
|
|
2025
Q4 | $1.47M | Buy |
2,531
+65
| +3% | +$36.8K | 0.07% | 150 |
|
|
2025
Q3 | $1.2M | Sell |
2,466
-611
| -20% | -$284K | 0.06% | 175 |
|
|
2025
Q2 | $1.25M | Sell |
3,077
-170
| -5% | -$71.1K | 0.07% | 185 |
|
|
2025
Q1 | $1.62M | Buy |
3,247
+84
| +3% | +$45.5K | 0.09% | 147 |
|
|
2024
Q4 | $1.65M | Buy |
3,163
+24
| +0.8% | +$13.2K | 0.1% | 137 |
|
|
2024
Q3 | $1.94M | Buy |
3,139
+1
| +0% | +$592 | 0.11% | 124 |
|
|
2024
Q2 | $1.74M | Sell |
3,138
-71
| -2% | -$40.7K | 0.09% | 126 |
|
|
2024
Q1 | $1.87M | Buy |
3,209
+40
| +1% | +$22.4K | 0.15% | 121 |
|
|
2023
Q4 | $1.68M | Sell |
3,169
-23
| -0.7% | -$11.1K | 0.14% | 125 |
|
|
2023
Q3 | $1.62M | Sell |
3,192
-167
| -5% | -$89K | 0.15% | 120 |
|
|
2023
Q2 | $1.75M | Sell |
3,359
-83
| -2% | -$44.8K | 0.16% | 110 |
|
|
2023
Q1 | $1.98M | Buy |
3,442
+9
| +0.3% | +$5.07K | 0.19% | 101 |
|
|
2022
Q4 | $1.89M | Sell |
3,433
-94
| -3% | -$49.8K | 0.2% | 102 |
|
|
2022
Q3 | $1.79M | Buy |
3,527
+75
| +2% | +$42K | 0.17% | 110 |
|
|
2022
Q2 | $2.07M | Buy |
3,452
+148
| +4% | +$81.5K | 0.18% | 96 |
|
|
2022
Q1 | $1.95M | Buy |
3,304
+150
| +5% | +$86.2K | 0.17% | 96 |
|
|
2021
Q4 | $2.1M | Buy |
3,154
+65
| +2% | +$40.6K | 0.18% | 90 |
|
|
2021
Q3 | $1.76M | Buy |
3,089
+46
| +2% | +$25.2K | 0.17% | 98 |
|
|
2021
Q2 | $1.53M | Buy |
3,043
+25
| +0.8% | +$11.8K | 0.15% | 115 |
|
|
2021
Q1 | $1.38M | Sell |
3,018
-38
| -1% | -$18.1K | 0.14% | 117 |
|
|
2020
Q4 | $1.42M | Sell |
3,056
-264
| -8% | -$124K | 0.15% | 115 |
|
|
2020
Q3 | $1.47M | Sell |
3,320
-15
| -0.4% | -$6.2K | 0.16% | 94 |
|
|
2020
Q2 | $1.21M | Buy |
3,335
+252
| +8% | +$84.5K | 0.14% | 102 |
|
|
2020
Q1 | $874K | Sell |
3,083
-260
| -8% | -$82K | 0.08% | 108 |
|
|
2019
Q4 | $1.09M | Sell |
3,343
-29
| -0.9% | -$8.79K | 0.15% | 107 |
|
|
2019
Q3 | $982K | Sell |
3,372
-88
| -3% | -$25.2K | 0.13% | 106 |
|
|
2019
Q2 | $1.02M | Buy |
3,460
+437
| +14% | +$120K | 0.13% | 107 |
|
|
2019
Q1 | $827K | Sell |
3,023
-53
| -2% | -$13.2K | 0.1% | 122 |
|
|
2018
Q4 | $688K | Sell |
3,076
-593
| -16% | -$139K | 0.09% | 132 |
|
|
2018
Q3 | $896K | Buy |
3,669
+38
| +1% | +$8.74K | 0.1% | 129 |
|
|
2018
Q2 | $752K | Buy |
3,631
+104
| +3% | +$22.1K | 0.09% | 137 |
|
|
2018
Q1 | $728K | Sell |
3,527
-687
| -16% | -$144K | 0.1% | 140 |
|
|
2017
Q4 | $800K | Buy |
4,214
+1,356
| +47% | +$260K | 0.11% | 128 |
|
|
2017
Q3 | $541K | Sell |
2,858
-127
| -4% | -$23K | 0.05% | 169 |
|
|
2017
Q2 | $521K | Sell |
2,985
-414
| -12% | -$69.5K | 0.06% | 168 |
|
|
2017
Q1 | $522K | Buy |
3,399
+255
| +8% | +$39K | 0.06% | 172 |
|
|
2016
Q4 | $444K | Sell |
3,144
-39
| -1% | -$5.75K | 0.06% | 192 |
|
|
2016
Q3 | $506K | Sell |
3,183
-53
| -2% | -$8.17K | 0.06% | 160 |
|
|
2016
Q2 | $478K | Buy |
3,236
+78
| +2% | +$11.5K | 0.05% | 163 |
|
|
2016
Q1 | $447K | Sell |
3,158
-213
| -6% | -$28.5K | 0.1% | 169 |
|
|
2015
Q4 | $478K | Buy |
3,371
+427
| +15% | +$57K | 0.12% | 155 |
|
|
2015
Q3 | $360K | Buy |
2,944
+321
| +12% | +$41.8K | 0.1% | 185 |
|
|
2015
Q2 | $340K | Sell |
2,623
-362
| -12% | -$47.2K | 0.09% | 204 |
|
|
2015
Q1 | $401K | Buy |
2,985
+484
| +19% | +$62.4K | 0.12% | 163 |
|
|
2014
Q4 | $313K | Buy |
2,501
+247
| +11% | +$30K | 0.12% | 189 |
|
|
2014
Q3 | $274K | Buy |
+2,254
| New | +$274K | 0.11% | 194 |
|
Other funds holding TMO
Checchi Capital Advisers's TMO Position: Q2 2026 in Review
Checchi Capital Advisers reduced its Thermo Fisher Scientific (TMO) stake by 0.07% in Q2 2026, selling an estimated $960 and leaving 2,709 shares worth $1.36M. The position accounts for 0.06% of the portfolio, ranked #169.
Checchi Capital Advisers first reported a position in TMO in Q3 2014 and has held it in 48 quarters since. The position peaked at $2.1M in Q4 2021. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Checchi Capital Advisers held 2,709 shares of Thermo Fisher Scientific worth $1.36M as of Q2 2026.
- Checchi Capital Advisers sold 2 Thermo Fisher Scientific shares in Q2 2026, an estimated $960.
- Thermo Fisher Scientific made up 0.06% of Checchi Capital Advisers's portfolio in Q2 2026, its #169 holding.
- Checchi Capital Advisers first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 48 quarters since.
- Checchi Capital Advisers's Thermo Fisher Scientific position peaked at $2.1M in Q4 2021.
- 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Checchi Capital Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.